Back to Journals » Infection and Drug Resistance » Volume 13

Ribaxamase, an Orally Administered β-Lactamase, Diminishes Changes to Acquired Antimicrobial Resistance of the Gut Resistome in Patients Treated with Ceftriaxone

Total article views   HTML views PDF downloads Totals
6,643 Dovepress* 5,428+ 900 6,328
PubMed Central* 1,215 154 1,369
Totals 6,643 1,054 7,697
*Since 22 July 2020
Total mentioned Facebook Delicious Reddit Twitter Others
8 0 0 0 4 4

View citations on PubMed Central and Google Scholar